Andy Y.

Andy Y. has a diverse work experience in the fields of biosciences, medical consultancy, education, and pharmaceuticals.

From 2017 to present, they have been serving as the Chief Scientific Officer at Artelo Biosciences, Inc., where they provide scientific expertise and leads the scientific advisory board.

Since 2015, Andy Y. has also been the Director of Blossom Medical Consultancy Ltd, a company that specializes in clinical, medical affairs, and business development activities.

In 2018, they joined The Centre for Medicinal Cannabis as the Pharmacy Lead, focusing on medicinal cannabis research and development.

Andy Y. has been an Honorary Lecturer at Keele University since 2016, contributing to the educational field.

Andy has also served as an Advisory Board Member at Dragonfly Biosciences since 2019.

In 2015, Andy Y. founded Kancerbis Ltd, a UK-based company that aims to provide new hope for cancer patients through the use of cannabinoids. Andy served as the Founder until 2018.

Earlier in their career, they held several roles at AstraZeneca, including Director of Global Analytics & Intelligence Cardiovascular and Metabolic Diseases, Corporate Business Development Director, Business Development Director in the Cardio-Metabolic Therapy Area, Global Brand Manager, and Global Medical Affairs Manager.

Andy Y. began their career as a PhD student at the University of Nottingham from 2001 to 2004.

Andy Y. completed a Bachelor of Pharmacy degree in Pharmacy from the University of Nottingham, from 1996 to 1999. Andy then pursued a PhD in Medicinal Chemistry from the same university, which they completed from 2001 to 2004.